Other News To Note
• Mesoblast Ltd., of Melbourne, Australia, received about $4.3 million under the Australian government's Innovation Australia Research and Development Tax Incentive Program. The funds will be used to advance development of Mesoblast's mesenchymal precursor cell technology platform and product pipeline.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter